This brand name is authorized in Nigeria.
The drug ALBETA N contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
G07GZ97H65 - CLOTRIMAZOLE
|
|
Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc. |
|
2
|
UNII
826Y60901U - BETAMETHASONE DIPROPIONATE
|
|
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |
|
3
|
UNII
057Y626693 - NEOMYCIN SULFATE
|
|
Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-2875 | Cream | ALBETA N CREAM CREAM 0.05%; 1%; 0.5% 30G | ALBETA N CREAM CLOTRIMAZOLE USP 1% W/W, BETAMETHASONE DIPROPIONATE 1. Clotrimazole USP Active 1.0 % 7.500 mg 2. Betamethasone Dipropionate eq. to Betamethasone USP Active 0.05 % 0.482 mg 3. Neomycin Sulphate USP Active 0.5 % 4.050 mg 4. Chlorocresol USNF Preservative 0.1 % 0.750 mg 5. Cetostearyl Alcohol BP Emulsion Stabilizer --- 45.00 mg 6. Cetomacragol 1000 BP Emulsifier --- 13.50 mg 7. Light Liquid Paraffin BP Soothing Agent --- 30.00 mg 8. White Soft Paraffin BP Soothing Agent --- 75.00 mg 9. B.H.T. BP Antioxidant --- 0.147 mg 10. Sodium Dihy B4-2875 Drugs Imported Products 30G Prescription Only Medicine (POM) 23/01/2023 JAMIN INTERNATIONAL CO. NIG. LTD, IHIALA STREET ODEKPE ONITSHA ANAMBRA 8077261675 jaminpharma@yahoo.com MAXHEAL PHARMACEUTICALS (INDIA) LIMITED, J-7, MIDC, TARAPUR INDUSTRIAL AREA, BOISAR, PALGHAR 401506, MAHARASHTRA STATE, INDIA, India | 26/04/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D07CC01 | Betamethasone and antibiotics | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics → D07CC Corticosteroids, potent, combinations with antibiotics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-2875 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.